Cidara Therapeutics Inc (CDTX)

23.22 +0.71 (+3.15%) USD  |  NASDAQ  |  Dec 20, 16:00
23.26 +0.04 (+0.17%) After-Hours: 20:00
More

Cidara Therapeutics Max Drawdown (5Y): 95.11% for Nov. 30, 2024

Max Drawdown (5Y) Chart

View Max Drawdown (5Y) for CDTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Max Drawdown (5Y) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Max Drawdown Definition

View Max Drawdown Definition
Start Trial

Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.

Read full definition.

Max Drawdown (5Y) Range, Past 5 Years

View Max Drawdown (5Y) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Max Drawdown (5Y) Benchmarks

View Max Drawdown (5Y) Benchmarks
Start Trial
Biomarin Pharmaceutical Inc 52.74%
Arbutus Biopharma Corp 95.31%
GlycoMimetics Inc 98.15%
FibroGen Inc 99.46%
Cue Biopharma Inc 98.52%

Max Drawdown (5Y) Related Metrics

Alpha (5Y) -33.02
Beta (5Y) 1.129
Annualized Standard Deviation of Monthly Returns (5Y Lookback) 88.26%
Historical Sharpe Ratio (5Y) -0.2033
Historical Sortino (5Y) -0.5002
Monthly Value at Risk (VaR) 5% (5Y Lookback) 33.02%